4.7 Review

Endocannabinoids and immune regulation

期刊

PHARMACOLOGICAL RESEARCH
卷 60, 期 2, 页码 85-92

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2009.03.019

关键词

Endocannabinoids; Immune response

资金

  1. NCCIH NIH HHS [P01 AT003961-01A1, P01 AT003961, P01AT003961] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL058641, R01 HL058641-02, R01HL058641] Funding Source: Medline
  3. NIAID NIH HHS [R01 AI058300, R01 AI058300-01, R01 AI053703, R01 AI053703-01, R01AI053703] Funding Source: Medline
  4. NIDA NIH HHS [R01DA016545, R01 DA016545-01, R01 DA016545-06, R01 DA016545] Funding Source: Medline
  5. NIEHS NIH HHS [R01ES09098, R01 ES009098-01A2, R01 ES009098, R01 ES009098-09] Funding Source: Medline

向作者/读者索取更多资源

Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response. Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders. (C) 2009 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据